10X Genomics Must Face Bio-Rad, Harvard Patent Suit

Law360 (April 30, 2020, 8:27 PM EDT) -- Life sciences company 10x Genomics Inc. lost a bid on Thursday to nix a patent case brought by Bio-Rad Laboratories Inc. and Harvard University, though the court did grant 10x Genomics' request to move part of the litigation from federal court in Massachusetts to California.

U.S. District Judge William G. Young shot down 10x Genomics' contention that Bio-Rad and Harvard had failed to show that the company knew about the purportedly infringed patents before it came out with its own line of "Next GEM Platform" biological analysis products that allegedly stepped on Bio-Rad and Harvard's intellectual property.

However, Judge Young said...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!